首页> 美国卫生研究院文献>other >The Relative Binding Affinities of PDZ Partners for CFTR: A Biochemical Basis for Efficient Endocytic Recycling
【2h】

The Relative Binding Affinities of PDZ Partners for CFTR: A Biochemical Basis for Efficient Endocytic Recycling

机译:PDZ伙伴对CFTR的相对结合亲和力:有效内吞再循环的生化基础。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial chloride channel mutated in patients with cystic fibrosis. Its expression and functional interactions in the apical membrane are regulated by several PDZ (PSD-95, discs large, zonula occludens-1) proteins, which mediate protein-protein interactions, typically by binding C-terminal recognition motifs. In particular, the CFTR-associated ligand (CAL) limits cell-surface levels of the most common disease-associated mutant ΔF508-CFTR. CAL also mediates degradation of wild-type CFTR, targeting it to lysosomes following endocytosis. Nevertheless, wild-type CFTR survives numerous cycles of uptake and recycling. In doing so, how does it repeatedly avoid CAL-mediated degradation? One mechanism may involve competition between CAL and other PDZ proteins including Na+/H+ Exchanger-3 Regulatory Factors 1 and 2 (NHERF1 and NHERF2), which functionally stabilize cell-surface CFTR. Thus, to understand the biochemical basis of WT-CFTR persistence, we need to know the relative affinities of these partners. However, no quantitative binding data are available for CAL or the individual NHERF2 PDZ domains, and published estimates for the NHERF1 PDZ domains conflict. Here we demonstrate that the affinity of the CAL PDZ domain for the CFTR C-terminus is much weaker than those of NHERF1 and NHERF2 domains, enabling wild-type CFTR to avoid premature entrapment in the lysosomal pathway. At the same time, CAL’s affinity is evidently sufficient to capture and degrade more rapidly cycling mutants, such as ΔF508-CFTR. The relatively weak affinity of the CAL:CFTR interaction may provide a pharmacological window for stabilizing rescued ΔF508-CFTR in patients with cystic fibrosis.
机译:囊性纤维化跨膜电导调节剂(CFTR) 是在囊性纤维化患者中发生突变的上皮氯化物通道。它在顶膜中的表达和功能性相互作用受几种PDZ(PSD-95,大盘状,小带闭塞-1)蛋白的调节,这些蛋白通常通过结合C端识别基序来介导蛋白-蛋白相互作用。特别是,CFTR相关配体(CAL)限制了最常见的疾病相关突变体ΔF508-CFTR的细胞表面水平。 CAL还介导了野生型CFTR的降解,将其靶向内吞后的溶酶体。尽管如此,野生型CFTR仍能承受许多吸收和循环利用的循环。这样,它如何反复避免CAL介导的降解?一种机制可能涉及CAL与其他PDZ蛋白(包括Na + / H + Exchanger-3调节因子1和2(NHERF1和NHERF2))之间的竞争,后者可在功能上稳定细胞-表面CFTR。因此,要了解WT-CFTR持久性的生化基础,我们需要了解这些伙伴的相对亲和力。但是,没有可用于CAL或单个NHERF2 PDZ域的定量结合数据,并且已发布的NHERF1 PDZ域的估计存在冲突。在这里,我们证明了CAL PDZ域对CFTR C端的亲和力比NHERF1和NHERF2域弱得多,从而使野生型CFTR可以避免溶酶体途径中的过早捕获。同时,CAL的亲和力显然足以捕获并降解循环更快的突变体,例如ΔF508-CFTR。 CAL:CFTR相互作用的相对较弱的亲和力可能为稳定囊性纤维化患者中获救的ΔF508-CFTR提供药理窗口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号